States with high concentrations of vulnerable populations, eg, older, sicker, but also poorer with basic needs unmet, face challenges as the COVID-19 lock-down lifts.
FDA Committee Supports Approval of Paxlovid for Treatment of COVID-19 in High-risk Adults
The FDA's Antimicrobial Drugs Advisory Committee voted 16-1 to support the approval of Paxlovid for the treatment of of mild-to-moderate COVID-19 in adults at high risk for severe disease.
Cold & Flu Season 2022-23: AAFP Board Chair Shares Concerns
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with American Academy of Family Physicians Board Chair Sterling Ransone, Jr, MD.
When is Myocarditis Most Severe? 2 Questions on Etiology
Research on myocarditis has found the risk for the condition significantly higher from infection with SARS-CoV-2 vs from mRNA vaccination against it. True or False?
Primary Viewpoints Episode 13: Possible Consequences of a Prolonged COVID-19 Era
"Primary Viewpoints," a podcast from Patient Care Online, brings you an exclusive interview with author and psychiatrist Samoon Ahmad, MD.
Novel Nasally-administered Monoclonal Antibody Reduces Inflammation in COVID-19
Delivered intranasally, the fully human anti-CD3 mAb Foralumab modulated T-cell inflammation in COVID-19 and may have wider application, say study authors.
COVID-19 Reinfection: Snapshot of the Pathology
Data presented at CROI 2023 demonstrated that periods of reinfection with the virus correlated with ascent of new variants and with time since first infection.